LevitaCare from INCUBA Next Level secures investment from Delphinus Venture Capital

An overlooked public health issue

Each year, around 60,000 women give birth in Denmark. The vast majority experience symptoms such as pain and a feeling of heaviness in the pelvic floor immediately after childbirth due to overstretched tissue and muscles. In the longer term, up to 50 percent of women who have given birth vaginally develop postpartum conditions such as pelvic organ prolapse and incontinence – with significant consequences for quality of life, working life and self-esteem.

Despite this, the area is often trivialised, and many women experience a lack of language, recognition and concrete treatment options.

This is a challenge that consultant gynaecologist and PhD in urogynaecology Karl Møller Bek has seen up close through more than four decades of clinical work.

“I have met countless women who come in with a clear sense that something is broken – and are told to just do pelvic floor exercises or wait it out. If a football player suffers a muscle injury, compression is used to support healing. The same principle should be entirely natural to apply after childbirth,” he says.

From clinical insight to a concrete solution

Building on this clinical experience, Karl Møller Bek, together with CEO Matilde Fevre, midwife Eva Dimon and engineer Mads Østergaard, has developed LevitaCare’s solution for women experiencing postpartum pelvic floor issues. The product has been developed in close dialogue with women who live with these conditions themselves.

“Postpartum conditions are not a niche problem. Half of the world’s population gives birth, and many women live with complications afterwards. When you can develop a solution that both makes a real difference for women and addresses a globally and structurally overlooked market, there is significant business potential,” says Matilde Fevre.

The team behind LevitaCare combines clinical expertise, midwifery knowledge and advanced product development with a clear ambition to move women’s health higher up the healthcare and investment agendas.

Women’s health is severely underinvested

Despite women making up half of the world’s population, only around six percent of private health investments today go towards women’s health. This is highlighted in a recent report by the World Economic Forum and Boston Consulting Group.

It is a trend that Delphinus Venture Capital actively wants to help change.

“Women’s health is a structurally underinvested area. Partly because the investment community has historically not reflected the target group, making it harder to recognise and understand problems you do not experience yourself, and partly because topics such as postpartum conditions have long been taboo and lacked a shared language. As these barriers begin to fall, substantial commercial and societal potential emerges,” says Katrine Haahr Riisberg, Investment Associate at Delphinus Venture Capital.

When Founder Hub and Investor Hub meet

The investment in LevitaCare is also a concrete example of the interaction between startups and investors at INCUBA Next Level, where Founder Hub and Investor Hub are brought together under one roof.

Here, capital, competencies and community come together in everyday life – often in informal settings – creating the foundation for new relationships, qualified ideas and investments to take shape.

“When startups and investors are part of the same environment, a different kind of dialogue and understanding emerges. It shortens and strengthens the path from idea to investment. LevitaCare and Delphinus Venture Capital are a strong example of how knowledge, capital and community can reinforce one another,” says Jacob Doktor Mogensen, CEO of INCUBA.

For LevitaCare, the investment represents a decisive step towards market entry. For Delphinus Venture Capital, it is an opportunity to support a solution that combines strong clinical insight, a clear societal need and a significant global market.